|
Volumn 75, Issue 21, 2010, Pages 1943-
|
The delayed-start study in Parkinson disease: Can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: Still no satisfaction?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RASAGILINE;
INDAN DERIVATIVE;
NEUROPROTECTIVE AGENT;
HUMAN;
LETTER;
NEUROPROTECTION;
PARKINSON DISEASE;
PATIENT CARE;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
PROFESSIONAL STANDARD;
CLINICAL TRIAL (TOPIC);
DRUG ADMINISTRATION;
NOTE;
CLINICAL TRIALS AS TOPIC;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
INDANS;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
|
EID: 78650010403
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/WNL.0b013e3181fac7f9 Document Type: Letter |
Times cited : (3)
|
References (0)
|